R

R&G PharmaStudies Co Ltd
SZSE:301333

Watchlist Manager
R&G PharmaStudies Co Ltd
SZSE:301333
Watchlist
Price: 49.52 CNY -4.55% Market Closed
Market Cap: 4.8B CNY
Have any thoughts about
R&G PharmaStudies Co Ltd?
Write Note

R&G PharmaStudies Co Ltd
Investor Relations

R&G PharmaStudies Co., Ltd. engages in the provision of clinical trial outsourcing services. The company is headquartered in Beijing, Beijing and currently employs 1,926 full-time employees. The company went IPO on 2022-08-02. The firm's main businesses include clinical trial operation services (CO Services), clinical trial site management services (SMO Services), biological sample testing services (BA Services), data management and statistical analysis services (DM/ST Services), clinical trials Consulting Services, Clinical Pharmacology Services (CP Services) and others. The firm operates its businesses primarily in the domestic market.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Jie Wu M.B.A.
Chairman & GM
No Bio Available
Ms. Qian Zhao
Chief Financial Officer
No Bio Available
Ms. Leyan Teng
COO, Senior VP & Director
No Bio Available
Dr. Gang Chen
Deputy GM & Chief Scientific Officer
No Bio Available
Mr. Wei Wang EMBA
Deputy GM & Director
No Bio Available
Mr. Jigang Li M.B.A.
Senior VP & Chief Medical Officer
No Bio Available
Dr. Ping Liu
General Manager of Lingchu Pharmaceutical Technology Co., Ltd.
No Bio Available
Dr. Shuqi Li
Senior VP, Board Secretary & Director
No Bio Available
Mr. Tao Wang
Deputy General Manager
No Bio Available

Contacts

Address
BEIJING
Beijing
11F, North Tower, Tower B, Huatong Mansion, No. 19, Chegongzhuang West Road, Haidian District
Contacts
+861088019152
www.rg-pharma.com